MedTrace Logo

Diabetic Treatment Adherence

NCT01318564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2016-09-12

No results posted yet for this study

Summary

The goal of this clinical research study is to test an investigational type of packaging for diabetes drugs called "unit-dose packaging." Researchers want to learn if unit-dose packaging can help patients with Type II diabetes to take their drugs on the proper schedule.

Conditions

  • Endocrine System Diseases

Interventions

DRUG

Metformin

500 - 1000 mg by mouth twice a day with either via a MEMS device pill bottle (medication event monitoring system) or by unit-dosing (blister packaging) with attached Med-ic device (electronic compliance monitoring for blistered medication).

BEHAVIORAL

Questionnaires

Completion on Day 1 and after Month 3. Each questionnaire to take about 30 minutes to complete.

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Maria Suarez-Almazor, MD,PHD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01318564 on ClinicalTrials.gov